GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, AKR1C3, APP, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MMP2, MMP9, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
13.6992 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP2, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TEK, TYR |
12.5175 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, CDC25B, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FLT3, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
12.3544 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, GSK3B, HSD17B2, IDO1, IGF1R, INSR, MMP2, MMP9, PPARA, PTGS2, RORC, SLC6A4, SRC, TEK, TYR |
11.3778 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DHFR, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, GSK3B, HRH3, HRH4, HSD17B1, HSD17B2, HSPA1A, INSR, KCNH2, KDR, KIT, MET, PPARA, PTGS2, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
10.7853 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, APP, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GSK3B, IGF1R, INSR, KIT, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK |
10.2856 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
10.1301 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, GSK3B, HSPA1A, INSR, KDR, KIT, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
9.88156 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, GSK3B, HSPA1A, INSR, KDR, KIT, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
9.87218 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.68472 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, APP, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, ESR1, FABP3, FABP4, HSD17B1, HSD17B2, KIT, MET, PPARA, PTGS2 |
9.53217 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HRH3, HRH4, HSPA1A, IDO1, IGF1R, KCNH2, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.41593 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AKR1C3, APP, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, KIT, MMP2, MMP9, PTGS2, RORC, SLC6A4, SMAD3, SRC, TERT |
9.34687 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HRH4, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
9.15818 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
8.96443 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AKR1C3, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, KIT, PPARA, PTGS2, SLC6A4, SRC, TEK |
8.96443 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
8.81245 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, GSK3B, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
8.72434 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, GSK3B, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
8.57714 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GSK3B, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.51069 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, HSD17B1, HSD17B2 |
8.49768 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GPR35, GSK3B, HSPA1A, INSR, KDR, KIT, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.49467 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX5, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, FABP4, HRH3, HSD17B2, IDO1, IGF1R, INSR, KCNH2, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TYR |
8.49467 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GSK3B, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.47397 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, PIM1, SRC, TEK |
8.47236 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, AURKB, AXL, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
8.47236 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, IDO1, PTGS2, RORC, SLC6A4, SRC, TYR |
8.47236 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
8.44736 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESRRA, FLT3, PTGS2, RORC, SLC6A4, SRC, TEK, TYR |
8.44736 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPR35, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
8.43389 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, KIT, MMP2, MMP9, NUAK1, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TERT |
8.30555 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, CA12, CA2, CA4, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, FABP3, HSPA1A, IDO1, PIM1, PPARA, PTGS2, TYR, XDH |
8.25107 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HRH3, HRH4, HSPA1A, IDO1, IGF1R, KCNH2, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
8.22157 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CSNK2A1, CYP1B1, EGFR, ESRRA, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IDO1, INSR, KDR, KIT, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.20032 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, AURKB, AXL, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
8.16635 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CYP19A1, DHFR, DUSP3, EGFR, ESR1, FABP4, GSK3B, HSPA1A, IDO1, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.16635 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, FLT3, GPR35, GSK3B, HRH4, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.91034 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, GPR35, GSK3B, HRH3, HSPA1A, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT |
7.62301 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, KIT, PPARA, SMAD3, SRC, TEK, TYR |
7.4685 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
7.36223 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, PTGS2, PTPN1, SRC, TEK, XDH |
7.28862 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, APP, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MMP2, PTGS2, RORC, SLC6A4, SMAD3, SRC |
7.28862 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.18443 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AKR1C3, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK, TERT |
7.15116 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.15116 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA9, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, GSK3B, HSD17B2, INSR, KDR, KIT, MET, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
7.03113 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, GSK3B, HRH3, HRH4, HSPA1A, IGF1R, INSR, KIT, MET, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.98273 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HRH3, HRH4, HSPA1A, IGF1R, INSR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.97403 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, GSK3B, HRH3, HRH4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
6.83482 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.79558 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, EGFR, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.78276 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HRH3, HRH4, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.72316 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, TYR |
6.70306 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, GSK3B, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.67128 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HRH3, HRH4, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.67128 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, EGFR, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.63247 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, APP, AURKB, CDC25B, CSNK2A1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
6.62668 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, EGFR, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.50147 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.45498 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.39723 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.35604 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.33962 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, EGFR, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.33962 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, GSK3B, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
6.33535 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, APP, EGFR, ESR1, FLT3, GSK3B, IGF1R, INSR, KIT, MMP2, PTGS2, SLC6A4, SMAD3, SRC |
6.31539 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GSK3B, HSD17B2, INSR, KDR, KIT, MMP9, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
6.29211 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS2 |
6.2674 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH |
6.24866 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH |
6.2299 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH |
6.14679 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9, DHFR |
6.11235 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
6.08378 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS2 |
6.06185 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.94105 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, GSK3B, HRH4, HSPA1A, IDO1, KIT, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.9349 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, FABP3, FABP4, KIT, MET, PPARA, PTGS2 |
5.90853 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, AKR1C3, CYP1A1, FABP3, FLT3, KIT, PPARA, PTGS2, RORC, SRC, TEK |
5.88464 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APP, AXL, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HRH4, INSR, KCNH2, MET, SMAD3, SRC, TERT |
5.85966 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APP, AURKB, AXL, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
5.82839 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AXL, CYP1B1, EGFR, ESR1, GSK3B, IGF1R, INSR, MMP2, MMP9, PTGS2, RORC, SLC6A4, SRC |
5.79054 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA, PTGS2 |
5.76734 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DHFR, EGFR, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TEK, TYR |
5.74751 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, GSK3B, HSPA1A, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
5.71556 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, HSPA1A, KIT, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
5.68235 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, AKR1C3, APP, AURKB, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
5.68139 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, APP, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPR35, GSK3B, HSPA1A, IDO1, INSR, KCNH2, KDR, KIT, MET, MMP12, MMP9, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
5.67408 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.6472 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
5.6431 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CA7, CYP19A1, EGFR, GPR35, GSK3B, HRH3, HSPA1A, INSR, KCNH2, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT |
5.63485 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APP, AURKB, AXL, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
5.49377 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, KIT, MMP9, PTGS2, TERT |
5.49079 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, APP, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HRH3, HRH4, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
5.4889 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
5.47192 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH |
5.46829 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, DHFR, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SLC6A4, SRC |
5.46829 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.44871 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC, TEK |
5.43279 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, EGFR, HRH3, INSR, PTGS2, SLC6A2, SLC6A4, SMAD3 |
5.38411 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DHFR, EGFR, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TEK, TYR |
5.38106 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.32723 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, CYP19A1, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.32201 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, APP, DUSP3, EGFR, FLT3, HRH4, IGF1R, INSR, KDR, KIT, PTPN1, SRC, TEK, XDH |
5.32201 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.27721 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, ESRRB, FABP4, FLT3, HRH4, IGF1R, INSR, KDR, KIT, MMP9, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
5.24553 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, EGFR, GSK3B, INSR, KCNH2, MMP12, PTGS2, SLC6A4, SMAD3, SRC, TERT |
5.24553 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.22637 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS2 |
5.20799 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, EGFR, HSPA1A, IDO1 |
5.19291 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.18987 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.18987 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, PTGS2, RORC, SLC6A4, SRC |
5.16428 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, KIT, MMP9, TERT |
5.13659 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, INSR, KIT, MET, SRC, TEK, XDH |
5.03306 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, GSK3B, KIT, PPARA, RORC, SLC6A4, SRC |
5.00949 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, INSR, KIT, MET, SRC, TEK |
4.98744 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS2 |
4.93256 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
4.93256 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.93146 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DHFR, EGFR, ESR1, ESR2, FLT3, GSK3B, HSPA1A, INSR, KIT, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.89427 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1C3, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HRH3, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
4.89175 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
4.87774 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
4.87748 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR |
4.82386 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, MMP9, SRC |
4.79877 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, IDO1, PPARA, PTGS2 |
4.79608 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AKR1C3, APP, AURKB, CSNK2A1, DHFR, DUSP3, ESR1, ESR2, ESRRA, FABP4, GSK3B, HRH3, HRH4, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
4.68639 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3, XDH |
4.68004 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, HRH4, INSR, KCNH2, MET, SMAD3 |
4.66125 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.65618 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, APP, AXL, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, IDO1, INSR, KIT, MMP2, MMP9, PTGS2, SLC6A4, SRC |
4.63546 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.57429 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HSD17B1, HSD17B2 |
4.5362 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HRH4, IGF1R, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
4.53012 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, APP, EGFR, FLT3, INSR, KDR, KIT, PTPN1, SRC, TEK, XDH |
4.52315 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, APP, AXL, CA2, CYP1B1, EGFR, ESRRB, HSPA1A, IDO1, KDR, KIT, MET, MMP12, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
4.50646 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DHFR, EGFR, FABP3, KCNH2, KDR, PTGS2, SLC6A2, SLC6A4, SRC |
4.46309 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PTGS2, SRC, TEK |
4.45595 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TYR |
4.4442 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
4.42958 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, APP, CDC25B, EGFR, ESRRB, FLT3, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
4.42462 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR |
4.41806 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, KIT, PTPN1, SRC |
4.38257 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DHFR, EGFR, ESR1, FLT3, GSK3B, HSPA1A, INSR, KIT, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.3601 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, AKR1C3, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HRH3, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
4.3601 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PTGS2, SRC |
4.35481 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.31413 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DHFR, DUSP3, EGFR, GSK3B, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, TERT, XDH |
4.2953 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, GSK3B, IGF1R, INSR, KIT, PTPN1, SRC, TEK |
4.2953 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GSK3B, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
4.2953 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
4.29319 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1C3, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HRH3, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
4.2891 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
4.2891 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
4.21586 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, GSK3B, HSPA1A, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.18977 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH |
4.13921 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
4.12559 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.12058 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, GPR35, HRH3, KCNH2, MMP9, PTGS2 |
4.11158 |
[BP] GO:0051172 |
None
|
ADRA2A, APP, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HRH3, HRH4, HSPA1A, IGF1R, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
4.09964 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, AURKB, AXL, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPR35, GSK3B, HRH3, HRH4, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
4.09964 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, SLC6A4, SRC, TERT |
4.08925 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.07015 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
AKR1C3, EGFR, INSR, PTGS2, SMAD3, XDH |
4.05651 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.04106 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.98688 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, APP, CDC25B, EGFR, FLT3, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
3.98445 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TYR |
3.97512 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DHFR, DUSP3, EGFR, ESR1, FLT3, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TYR, XDH |
3.96995 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, EGFR, ESR1, FLT3, GSK3B, HSPA1A, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.93891 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, PPARA, PTGS2, SMAD3, TEK |
3.93617 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
3.91497 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, KIT, PTGS2, SLC6A4 |
3.91497 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, KIT, PTGS2, SLC6A4 |
3.91497 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TYR |
3.89832 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, AXL, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, KIT, PTGS2, SRC |
3.89832 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC |
3.88063 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4, SRC, TEK |
3.88063 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.83075 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, PTPN1, SRC, TEK |
3.83075 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.83075 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS2 |
3.82934 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HRH3, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
3.81865 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GSK3B, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.80234 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, EGFR, FLT3, KIT, PTPN1, SRC |
3.80138 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CA2, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, GSK3B, HRH3, HRH4, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK |
3.76589 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GSK3B, IDO1, INSR, KDR, KIT, NUAK1, PIM1, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.73434 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CES1, CYP19A1, CYP1A1, CYP1B1, DHFR, TYR |
3.72023 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.68918 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.65442 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.65442 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.65442 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD17B1, HSD17B2 |
3.63083 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.61502 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC |
3.60789 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, ESR1, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.5908 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, MMP9, SRC |
3.58711 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, EGFR, ESR1, FLT3, KIT, MET, PIM1, SRC, TEK, TYR |
3.5525 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DHFR, EGFR, PPARA, SMAD3 |
3.51094 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SMAD3, SRC, TERT |
3.50889 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, KDR, MET, MMP12, PPARA, PTGS2, SMAD3, TEK |
3.50889 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.49915 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, FABP4, FLT3, GSK3B, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.48293 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.47976 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, PTPN1, SRC |
3.47976 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
3.42548 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, KIT, PTPN1, SRC |
3.41829 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR, PTGS2 |
3.4078 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
3.4078 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, IDO1 |
3.40089 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AXL, CYP19A1, ESR1, HSD17B2, INSR, KIT, SRC |
3.35805 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
3.35805 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2, SLC6A4 |
3.35296 |
[BP] GO:0050890 |
None
|
ADORA1, APP, EGFR, HRH3, INSR, KIT, PTGS2, SLC6A4 |
3.33783 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
3.33611 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
3.33547 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.33547 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
3.32429 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CES1, CYP19A1, HSD17B1, HSD17B2 |
3.32429 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
3.28646 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, CYP1B1, FABP3, HSPA1A, IDO1, PTGS2, SLC6A4, SMAD3, TERT, XDH |
3.27825 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, GSK3B, IDO1, INSR, KDR, KIT, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.26132 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC, TERT |
3.25406 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KCNH2, KDR, PTGS2, SRC |
3.24239 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, APP, AXL, CDC25B, CES1, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FLT3, GSK3B, KDR, KIT, MET, MMP2, MMP9, PTGS2, RORC, SMAD3, SRC, TEK, TERT |
3.23354 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ESR1, GSK3B, HSPA1A, KDR, KIT, MET, MMP1, SMAD3, SRC, TEK |
3.18346 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4, SRC, TEK |
3.17866 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPR35, GSK3B, HRH3, HRH4, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.17486 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, CA2, CA7, GPR35, HRH3, KCNH2, MMP9, PTGS2, SLC6A4 |
3.12424 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, APP, GPR35, GSK3B, HRH3, HSPA1A, KCNH2, MMP9, PTGS2 |
3.11417 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, IGF1R, KDR, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
3.10875 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, KIT, PTPN1, SRC |
3.06436 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, KIT, PTGS2 |
3.047 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
3.03715 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.03495 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
3.03161 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
3.03161 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
3.03161 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
3.03161 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
3.03161 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DUSP3, INSR, TERT |
3.03161 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, ADRA2A, AKR1C3, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GSK3B, HRH3, HRH4, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TERT |
3.03058 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TERT |
3.03058 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTGS2, RORC, SMAD3, SRC, TERT |
3.03058 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
ADRA2A, APP, CSNK2A1, DUSP3, FABP4, GSK3B, HRH3, HRH4, IGF1R, MMP9, PTGS2, PTPN1, SRC |
3.01985 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
3.0064 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
3.0064 |
[BP] GO:1900180 |
regulation of protein localization to nucleus
|
APP, EGFR, GSK3B, PTGS2, SMAD3, SRC, TERT |
3.00385 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
3.00105 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
3.00105 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.99357 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.96058 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.93141 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, GSK3B, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.88124 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, APP, CDC25B, EGFR, FLT3, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
2.8677 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, TEK |
2.85613 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT |
2.8445 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, GSK3B, HSPA1A, IDO1, SRC, XDH |
2.82836 |
[BP] GO:0042136 |
neurotransmitter biosynthetic process
|
ACHE, CYP1B1, DHFR, SLC6A4 |
2.82196 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.80614 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.80308 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, EGFR, FLT3, INSR, KIT, PTPN1, SRC, TEK |
2.79575 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, EGFR, ESR1, FABP3, GPR35, HRH4, KCNH2, SMAD3 |
2.79575 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.79575 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.79575 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, CYP1B1, EGFR, HRH3, INSR, KCNH2, KIT, PTGS2, SLC6A4, SRC, TEK, TYR |
2.79575 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CYP1A1, EGFR, ESR1, KIT, PTGS2, SLC6A4, SRC |
2.78634 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, CES1, CYP19A1, DHFR, TYR |
2.7845 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.7845 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, PTPN1, RORC, SMAD3, SRC, TERT |
2.7845 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, KIT, TEK |
2.77851 |
[BP] GO:0016101 |
None
|
AKR1B10, AKR1C3, CYP1A1, CYP1B1, EGFR |
2.77851 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX5, CES1, CYP19A1, CYP1A1, DHFR, IDO1, PTGS2 |
2.77687 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, PTGS2 |
2.7755 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.73961 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, APP, CA2, EGFR, GSK3B, MMP12, PTGS2, PTPN1, SMAD3, SRC |
2.73757 |
[BP] GO:2000351 |
None
|
AKR1C3, KDR, TEK, TERT |
2.73757 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, GSK3B, HSPA1A, INSR, KDR, PPARA, PTPN1 |
2.73722 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, EGFR, FLT3, INSR, KIT, PTPN1, SRC, TEK |
2.72367 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, AKR1C3, EGFR, ESR1, FLT3, INSR, KIT, SRC |
2.72067 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.71566 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.71566 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.71566 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.71566 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AXL, CA2, CYP1B1, ESRRB, IDO1, INSR, KDR, KIT, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
2.69422 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, SMAD3, TEK |
2.67975 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, SRC, TEK |
2.67838 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.67013 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, KIT, PTPN1, SRC |
2.66253 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.6601 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.6601 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.6601 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, KIT, PTPN1, SRC |
2.6601 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
2.6473 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.64509 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.64509 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.64509 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.64509 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, KDR, KIT, PTGS2, TEK, TERT |
2.64304 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, PPARA, PTGS2, RORC, SMAD3, SRC, TERT |
2.64042 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.63911 |
[BP] GO:0071396 |
cellular response to lipid
|
AKR1C3, AXL, EGFR, ESR1, FLT3, RORC, SLC6A4, SRC |
2.63843 |
[BP] GO:0031326 |
regulation of cellular biosynthetic process
|
ADORA3, ADRA2A, AKR1C3, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GSK3B, HRH3, HRH4, HSPA1A, IGF1R, INSR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TERT |
2.61632 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.61404 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.61404 |
[BP] GO:0008406 |
gonad development
|
AKR1C3, CYP19A1, ESR1, INSR, KIT |
2.60604 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CSNK2A1, EGFR, FLT3, GPR35, GSK3B, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
2.5737 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPR35, GSK3B, HRH3, HRH4, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.5737 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, EGFR, KDR, PTGS2, SRC |
2.56468 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.53258 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.53258 |
[BP] GO:0031327 |
None
|
ADRA2A, AKR1C3, AURKB, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HRH3, HRH4, HSPA1A, MMP12, PPARA, RORC, SMAD3, SRC |
2.51369 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
2.50642 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.50054 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, EGFR, ESR1, ESR2, ESRRA, ESRRB, GSK3B, HSPA1A, INSR, KIT, MET, MMP12, PPARA, RORC, SLC6A4, SMAD3, SRC, TERT |
2.49455 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.49166 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, AKR1C3, APP, CES1, CYP1B1, DHFR |
2.49104 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TERT |
2.48761 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 |
2.46373 |
[BP] GO:0009890 |
None
|
ADRA2A, AKR1C3, AURKB, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HRH3, HRH4, HSPA1A, MMP12, PPARA, RORC, SMAD3, SRC |
2.45744 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
GSK3B, HSPA1A, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT |
2.45744 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, GSK3B, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.45287 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.44921 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.44921 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.4418 |
[BP] GO:0007584 |
response to nutrient
|
AKR1C3, CYP1A1, EGFR, PTGS2, SLC6A4, TYR |
2.4418 |
[BP] GO:0071229 |
cellular response to acid chemical
|
AKR1C3, EGFR, KDR, MMP2, SLC6A4, SRC |
2.43266 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
APP, CSNK2A1, EGFR, ESR1, GSK3B, HSPA1A, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, XDH |
2.42975 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, CYP1B1, ESR1, ESR2, HSPA1A, KIT, PIM1 |
2.41429 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, HRH3 |
2.40164 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.40164 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.39808 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.39808 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.39808 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, AKR1C3, AXL, CA2, CA9, CYP1B1, DHFR, EGFR, GSK3B, HSPA1A, MMP9, NUAK1, PTGS2, PTPN1, SRC, TERT |
2.39767 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, CYP1B1, EGFR, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PTPN1, SRC, TEK |
2.39641 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, CA2, CYP19A1, DUSP3, ESR1, ESRRA, HSPA1A, IDO1, KIT, MMP12, MMP2, PTPN1, SMAD3, SRC |
2.39409 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, HSPA1A, IDO1, MMP12, PTGS2, SMAD3, SRC |
2.37721 |
[BP] GO:0031331 |
positive regulation of cellular catabolic process
|
ADRA2A, ESRRB, GSK3B, HSPA1A, INSR, KDR, PPARA, PTPN1 |
2.37721 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, PTGS2, SLC6A4 |
2.37581 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 |
2.37387 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 |
2.37387 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.36374 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.36374 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, EGFR, FLT3, INSR, KIT, PTPN1, SRC |
2.35663 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.35663 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA2A, KIT, PTGS2 |
2.35663 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, CA12, CA2, CA7, EGFR, ESR1, GPR35, HRH4, KCNH2, SMAD3 |
2.33558 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CES1, CYP1A1, CYP1B1, KDR, SLC6A4, SRC |
2.33452 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, KDR, KIT, TEK |
2.3337 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.3331 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, EGFR, GPR35, KCNH2, KIT, PTGS2, SMAD3 |
2.33024 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, GSK3B, HSPA1A, IDO1, XDH |
2.32451 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.32451 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GSK3B, IGF1R, INSR, SRC |
2.30245 |
[BP] GO:0046683 |
response to organophosphorus
|
APP, PTGS2, SLC6A4, TEK, TYR |
2.29206 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.29103 |
[BP] GO:0005979 |
None
|
ESRRB, GSK3B, INSR |
2.27924 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.27924 |
[BP] GO:0006693 |
None
|
AKR1C3, CES2, PTGS2 |
2.27924 |
[BP] GO:0006692 |
None
|
AKR1C3, CES2, PTGS2 |
2.27924 |
[BP] GO:0010962 |
None
|
ESRRB, GSK3B, INSR |
2.27924 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
HSPA1A, MMP9, PTGS2, PTPN1, SRC, TERT |
2.27924 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 |
2.27165 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 |
2.25895 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.25895 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.25119 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.24594 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.24594 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPR35, GSK3B, HRH3, HRH4, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.24594 |
[BP] GO:0031349 |
positive regulation of defense response
|
EGFR, FABP4, HSPA1A, IDO1, MMP12, MMP2, PTGS2, SRC |
2.24594 |
[BP] GO:0015711 |
organic anion transport
|
CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.24594 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.24374 |
[BP] GO:1900543 |
None
|
ADRA2A, HRH3, HRH4, PPARA |
2.24118 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.2399 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH |
2.2339 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.2339 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.2339 |
[BP] GO:0014050 |
None
|
ADORA1, HRH3 |
2.2339 |
[BP] GO:0031099 |
regeneration
|
AXL, CSNK2A1, DHFR, EGFR, FLT3 |
2.23293 |
[BP] GO:0007623 |
circadian rhythm
|
EGFR, GSK3B, PPARA, RORC, SLC6A4 |
2.23293 |
[BP] GO:0051248 |
None
|
APP, CSNK2A1, DHFR, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
2.23293 |
[BP] GO:0030155 |
regulation of cell adhesion
|
CYP1B1, DUSP3, GSK3B, IDO1, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.23246 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AURKB, AXL, CSNK2A1, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK |
2.23188 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, EGFR, INSR, KIT, PTPN1, SRC |
2.23188 |
[BP] GO:0045980 |
None
|
ADRA2A, HRH3, HRH4, PPARA |
2.23188 |
[BP] GO:0051241 |
negative regulation of multicellular organismal process
|
ADORA1, APP, AXL, EGFR, GPR35, GSK3B, IDO1, PTGS2, SLC6A4, SMAD3, TEK, TERT, XDH |
2.23188 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, CA2, EGFR, FLT3, PTGS2, SRC |
2.22202 |
[BP] GO:0045934 |
None
|
ADRA2A, AURKB, ESR1, ESR2, ESRRA, FABP4, HRH3, HRH4, HSPA1A, MMP12, PPARA, RORC, SMAD3, SRC, TERT |
2.21874 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.21183 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ALOX5, APP, AXL, EGFR, FLT3, HSPA1A, KIT, MMP9, RORC, SMAD3, SRC |
2.20136 |
[BP] GO:0071383 |
None
|
AKR1C3, EGFR, FLT3, SRC |
2.19248 |
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, APP, PTPN1 |
2.19248 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, AXL, CYP1A1, EGFR, PTGS2, SLC6A4, SRC, TYR |
2.17509 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, APP |
2.17509 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ESR1, GSK3B, HSPA1A, MET, MMP1, SRC |
2.16797 |
[BP] GO:1904035 |
regulation of epithelial cell apoptotic process
|
AKR1C3, KDR, TEK, TERT |
2.15379 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.15379 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.13666 |
[BP] GO:0070873 |
None
|
ESRRB, GSK3B, INSR |
2.13666 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.13666 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.13666 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.1362 |
[BP] GO:0014074 |
response to purine-containing compound
|
APP, PTGS2, SLC6A4, TEK, TYR |
2.1125 |
[BP] GO:1901342 |
regulation of vasculature development
|
CYP1B1, KDR, KIT, PTGS2, TEK, TERT, XDH |
2.1102 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.10223 |
[BP] GO:2000352 |
None
|
KDR, TEK, TERT |
2.10223 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.10223 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.10223 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.10223 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.10223 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A4 |
2.10223 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A4 |
2.10223 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A4 |
2.10223 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A4 |
2.10223 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.10223 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19 |
2.10223 |
[BP] GO:1900542 |
None
|
ADRA2A, ESRRB, HRH3, HRH4, INSR, PPARA |
2.10066 |
[BP] GO:0070542 |
None
|
AKR1C3, FABP3, PTGS2, SRC |
2.09232 |
[BP] GO:0007611 |
None
|
APP, EGFR, INSR, KIT, PTGS2, SLC6A4 |
2.09232 |
[BP] GO:0006091 |
generation of precursor metabolites and energy
|
AKR1B1, AOX1, CYP19A1, CYP1A2, GSK3B, IDO1, XDH |
2.08999 |
[BP] GO:0019219 |
regulation of nucleobase-containing compound metabolic process
|
ADORA3, ADRA2A, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, HRH3, HRH4, HSPA1A, IGF1R, INSR, KIT, MET, MMP12, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TERT |
2.08635 |
[BP] GO:0051254 |
None
|
APP, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TERT |
2.08635 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.08569 |
[BP] GO:0007194 |
None
|
ADRA2A, HRH3, HRH4 |
2.07842 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.07842 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07842 |
[BP] GO:0043255 |
regulation of carbohydrate biosynthetic process
|
ESRRB, GSK3B, INSR, PPARA |
2.07842 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AXL, CA2, CA9, CYP1B1, EGFR, ESR1, INSR, MET, MMP2, SLC6A4, SMAD3, SRC, TEK |
2.06897 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, HRH3 |
2.06361 |
[BP] GO:0033273 |
response to vitamin
|
CYP1A1, EGFR, PTGS2, TYR |
2.06361 |
[BP] GO:1903426 |
None
|
EGFR, INSR, PTGS2, SMAD3 |
2.06361 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.06361 |
[BP] GO:0006140 |
None
|
ADRA2A, ESRRB, HRH3, HRH4, INSR, PPARA |
2.04957 |
[BP] GO:1902893 |
None
|
PPARA, SMAD3, TERT |
2.04957 |
[BP] GO:0106027 |
None
|
APP, IGF1R, INSR |
2.04957 |
[BP] GO:0032885 |
regulation of polysaccharide biosynthetic process
|
ESRRB, GSK3B, INSR |
2.04957 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
EGFR, ESR1, KIT |
2.04957 |
[BP] GO:1904063 |
None
|
ADRA2A, GPR35, KCNH2, MMP9 |
2.04818 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, KDR, PTGS2, TEK, TERT |
2.04243 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.04237 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, EGFR, FLT3, PTGS2, SRC |
2.03137 |
[BP] GO:1901989 |
None
|
APP, CDC25B, CYP1A1, TERT |
2.03137 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, SMAD3, SRC |
2.01856 |
[BP] GO:0032148 |
None
|
ADRA2A, INSR, SRC |
2.01856 |
[BP] GO:0031280 |
None
|
ADRA2A, HRH3, HRH4 |
2.01856 |
[BP] GO:0032092 |
positive regulation of protein binding
|
APP, GSK3B, MMP9, TERT |
2.01795 |
[BP] GO:0010595 |
positive regulation of endothelial cell migration
|
KDR, MET, PTGS2, TEK |
2.01795 |
[BP] GO:0045936 |
None
|
ADRA2A, DUSP3, FABP4, HRH3, HRH4, IGF1R, PPARA, PTPN1, XDH |
2.00564 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.00181 |
[BP] GO:0010563 |
None
|
ADRA2A, DUSP3, FABP4, HRH3, HRH4, IGF1R, PPARA, PTPN1, XDH |
2.00181 |
[CC] GO:0045121 |
membrane raft
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
3.99125 |
[CC] GO:0098857 |
membrane microdomain
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
3.97512 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, EGFR, ESR1, FLT3, GPR35, GSK3B, HRH3, HRH4, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
3.80138 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, TEK |
3.41829 |
[CC] GO:0098589 |
membrane region
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
3.41373 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, APP, AXL, CA2, CA4, CA9, DUSP3, EGFR, FLT3, GPR35, HRH3, IGF1R, INSR, KCNH2, KDR, KIT, MET, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
3.14333 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, APP, AXL, CA4, FLT3, GPR35, HRH3, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A4, TEK |
2.56119 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, APP, AXL, FLT3, GPR35, HRH3, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A4, TEK |
2.27276 |
[CC] GO:0005783 |
None
|
ADORA1, APP, CA4, CES1, CES2, CYP19A1, FLT3, HSPA1A, KDR, PTGS2, PTPN1, XDH |
2.25044 |
[CC] GO:0009986 |
cell surface
|
ACHE, APP, AXL, CA4, EGFR, KCNH2, MET, SLC6A2, TEK |
2.23188 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.10223 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, AURKB, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, INSR, KCNH2, KDR, KIT, MMP2, MMP9, PIM1, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, TYR, XDH |
2.01795 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
13.0105 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, APP, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
11.0515 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, DUSP3, EGFR, FLT3, GSK3B, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, TERT, TYR, XDH |
10.2042 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.96443 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
8.30555 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.26129 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PPARA, SLC6A4, SRC, TEK |
6.77164 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
6.72316 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.54838 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
6.53559 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HRH3, HRH4, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, TEK |
6.45498 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, APP, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TYR, XDH |
6.31539 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
6.15472 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, APP, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TYR, XDH |
6.00799 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SMAD3, SRC |
5.77271 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HRH3, HRH4, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, TEK |
5.6454 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HRH3, HRH4, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, SMAD3, TEK |
5.60231 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
5.60031 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC |
5.5349 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, IDO1, PTGS2, SRC |
5.46829 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR, KIT |
5.45854 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, HRH3, HRH4, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, TEK |
5.45073 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.43058 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.43058 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, IDO1, PTGS2, SRC |
5.26329 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.17201 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
5.16948 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
5.13659 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.00714 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TERT |
4.98724 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGS2, TYR |
4.93256 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
4.84403 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, HSD17B1, IDO1, PTGS2, SRC, XDH |
4.75981 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, KIT, MET, MMP9, PTGS2, SLC6A4, SMAD3, TERT, TYR, XDH |
4.75486 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRB, GSK3B, HSPA1A, KCNH2, KIT, MET, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK |
4.50082 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.45657 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
4.24895 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.20432 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, HSD17B1, HSD17B2, XDH |
4.20432 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
4.15394 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.89832 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.70519 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.65442 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.57608 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
3.46619 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.33349 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
3.27504 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
3.03161 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.03161 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.01869 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, FLT3, KCNH2, KIT, PTGS2, SLC6A4, SMAD3, TERT, TYR, XDH |
2.81555 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, EGFR, FLT3, GPR35, HRH3, HRH4, IGF1R, INSR, KDR, KIT, MET, TEK |
2.72553 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, EGFR, FLT3, GPR35, HRH3, HRH4, IGF1R, INSR, KDR, KIT, MET, TEK |
2.72553 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FLT3, GSK3B, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.72111 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FLT3, GSK3B, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.72067 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AXL, EGFR, FLT3, KCNH2, KIT, PTGS2, SLC6A4, SMAD3, TERT, TYR, XDH |
2.71566 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.64509 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.64509 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.64509 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.55835 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.5422 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
2.53785 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.44165 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, HSD17B1, HSD17B2 |
2.43426 |
[MF] GO:0043168 |
anion binding
|
AOX1, APP, AURKB, AXL, CSNK2A1, DHFR, EGFR, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.42158 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.41406 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.39808 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.39808 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.39808 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, KIT, SMAD3 |
2.39795 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.39744 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.29206 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.27924 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.27924 |
[MF] GO:0019900 |
None
|
ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, GSK3B, PTPN1, SMAD3, SRC |
2.26321 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD17B1, HSD17B2 |
2.24374 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.24374 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.2339 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.2339 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSD17B1, PPARA, RORC |
2.20382 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD17B1, HSD17B2 |
2.17509 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.17509 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.10223 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A4 |
2.10223 |
[MF] GO:0055131 |
None
|
HSPA1A, KCNH2 |
2.10223 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.10223 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2 |
2.10223 |
[MF] GO:0004969 |
None
|
HRH3, HRH4 |
2.10223 |
[MF] GO:0019901 |
None
|
ADRA2A, CDC25B, DUSP3, EGFR, ESR1, GSK3B, PTPN1, SMAD3, SRC |
2.06878 |
[MF] GO:0008013 |
beta-catenin binding
|
CSNK2A1, ESR1, GSK3B, SMAD3 |
2.06361 |
[MF] GO:0008134 |
transcription factor binding
|
ESR1, ESRRB, FLT3, GSK3B, PIM1, PPARA, SMAD3, SRC, TERT |
2.01856 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2C19 |
2.01856 |